Eli Lilly and Company: Lilly reports fourth-quarter 2025 financial results and provides ...

Revenue in Q4 2025 increased 43% to $19.3 billion driven by volume growth from Mounjaro and Zepbound. Q4 2025 EPS increased by 51% to $7.39 on a reported basis and ...